Use of a novel topical hemostatic sealant in lacrimal surgery: A prospective, comparative study

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 1, 2007, Pages 25-27

  Durrani, Omar M ^a   Fernando, Arosha I ^a   Reuser, Tristan Q ^b,c  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c Midland Eye Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLOSEAL; SEALANT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DACRYOCYSTORHINOSTOMY; HEMOSTASIS; HUMAN; HYPOTHESIS; LACRIMAL SURGERY; NOSE; NOSE SURGERY; PATIENT SATISFACTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

DACRYOCYSTORHINOSTOMY; GELATIN SPONGE, ABSORBABLE; HEMOSTASIS; HEMOSTATICS; HUMANS; LACRIMAL DUCT OBSTRUCTION; NASOLACRIMAL DUCT; PROSPECTIVE STUDIES;

EID: 33846444910     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e31802c610b     Document Type: Article

References (17)

1. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol Head Neck Surg 2004;131:601-5.
2. Baumann A, Caversaccio M. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal). Rhinology 2003;41:244-9.
3. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 2005;115:899-902.
4. Ellegala DB, Maartens NF, Laws ER Jr. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 2002;51:513-5.
5. Oz MC, Cosgrove DM, Badduke BR, et al. Controlled clinical trial of a novel haemostatic agent in cardiac surgery. Ann Thorac Surg 2000;69:1376-82.
6. Weaver FA, Hood DB, Zatina M, et al. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 2002;16:286-93.
7. Schonauer C, Tessitore E, Barbagallo G, et al. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 2004;13(Suppl 1):S89-96.
8. Renkens KL, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomised trial evaluating a new haemostatic agent for spinal surgery. Spine 2001;26:1645-50.
9. Jorgensen S, Bascom DA, Partsafas A, Wax MK. The effect of 2 sealants (FloSeal and Tisseel) on fasciocutaneous flap revascularization. Arch Facial Plast Surg 2003;5:399-402.
10. Maccabee MS, Trune DR, Hwang PH. Effects of topically applied biomaterials on paranasal sinus mucosal healing. Am J Rhinol 2003;17:203-7.
11. Vogel A, O'Grady K, Toriumi DM. Surgical tissue adhesives in facial plastic and reconstructive surgery. Facial Plast Surg 1993;9:49-57.
12. Civelek B, Kargi AE, Sensoz O, et al. Rare complication of nasal packing: alar region necrosis. Otolaryngology 2002;123:656-7.
13. Jahannessen N, Jensen PF, Kristensen S. Nasal packing and nocturnal oxygen desaturation. Acta Otolaryngol Suppl 1992;492:6-8.
14. Jacobson JA, Kasworm EM. Toxic shock syndrome after nasal surgery. Arch Otolaryngol Head Neck Surg 1986;112:329-32.
15. Viaman M, Segal S, Eviatar E. Fibrin glue treatment for epistaxis. Rhinology 2002;40:88-91.
16. Fairbanks DN. Complications of nasal packing. Otolayngol Head Neck Surg 1986;94:412-5.
17. Nichols WL, O'Marcaigh AS, Daniels PK, et al. Incidence on immune-mediated coagulopathies associated with surgical use of fibrin sealant ('glue') or bovine topical thrombin. Thomb Haemost 1997;78(Suppl 1):177.